Study guide
39.2 Nephrology: Acute Kidney Injury, Chronic Kidney Disease and Dialysis, Sodium and Potassium Disorders, Acid-Base Analysis, Urinary Tract Infections, Glomerular Diseases (Nephritic and Nephrotic), Kidney Stones, Renal Tumors and Sexually Transmitted Infections
Philippine Physician Licensure Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: PLE Structure, Eligibility & Study Strategy
1.1 PLE Format, 2026 Schedule & the Statutory Passing Rule 1.2 Eligibility, Internship, PRC Filing & Test-Day Rules 1.3 Reading the 2025 Tables of Specifications & Building a Study Plan
2 Chapter 2: Physiology I: Cells, Blood, Nerve & Muscle
2.1 Homeostasis, Cell Function, Membrane Transport & Resting Potential 2.2 Blood Cells, Immunity, Hemostasis, Fibrinolysis & Blood Distribution 2.3 Action Potentials, Conduction, the Neuromuscular Junction & Muscle Contraction
3 Chapter 3: Physiology II: Cardiovascular & Respiratory Systems
3.1 Cardiac Electrophysiology, the Cardiac Cycle & the Heart as a Pump 3.2 Circulation: Resistance, Venous Return, Coronary Flow, Microcirculation & Fetal Circulation 3.3 Respiratory Mechanics, Gas Exchange, Gas Transport, Control of Breathing & Extreme Environments
4 Chapter 4: Physiology III: Gastrointestinal, Endocrine, Renal & Reproductive Systems
4.1 Gastrointestinal Physiology: Secretion, Motility, Digestion & Absorption 4.2 Endocrine Physiology: Hormone Chemistry, Axes, Calcium & Fuel Regulation 4.3 Renal Physiology, Body Fluid Balance & Acid-Base Regulation 4.4 Reproductive Physiology: Sexual Differentiation, Spermatogenesis, the Menstrual Cycle, Parturition & Lactation
5 Chapter 5: Physiology IV: Neurophysiology & Special Senses
5.1 Sensory Receptors, Somatic Sensation, Spinal Reflexes & Motor Control 5.2 Higher Brain Functions, Sleep, the Autonomic Nervous System, Cerebral Blood Flow & the Special Senses
6 Chapter 6: Legal Medicine I: Medicolegal Examination, Identification & Death
6.1 The Medicolegal Examination, Physical Evidence & the Crime Scene 6.2 Identification of the Living, the Dead & Skeletal Remains 6.3 Thanatology: Death, Brain Death, Postmortem Changes & Time of Death
7 Chapter 7: Legal Medicine II: Injuries, Sexual Crimes, Reproduction, Mental State & Poisoning
7.1 Physical Injuries: Revised Penal Code Classes, Wounds, Gunshot Injuries, Asphyxia & Burns 7.2 Sexual Crimes, Violence Against Women & Child Abuse 7.3 Medicolegal Aspects of Pregnancy, Delivery, Abortion, Infanticide, Paternity & Marriage 7.4 Disturbance of Mentality: Insanity, Intoxication, Capacity & the Mental Health Act 7.5 Forensic Toxicology & Poisoning: Diagnosis, Evidence, Antidotes & Philippine Laws
8 Chapter 8: Legal Medicine III: Reports, Regulation, Liability & Ethics
8.1 The Medicolegal Report, the Death Certificate, Autopsy Rules & Communicating with Relatives 8.2 Licensure & Regulation of Medical Practice: RA 2382, the Board of Medicine, PRC & Prescribing Laws 8.3 Medical Malpractice: Civil, Criminal & Administrative Liability and Key Philippine Doctrines 8.4 Physician Relationships Under the PMA Code of Ethics: Patients, Colleagues, Allied Health, Students, Industry, HMOs, Hospitals & PhilHealth 8.5 Bioethical Principles, Informed Consent, Confidentiality, End-of-Life & Research Ethics
9 Chapter 9: Pathology I: Cell Injury, Inflammation & Hemodynamics
9.1 Cell Injury, Adaptation, Necrosis, Apoptosis, Accumulations & Calcification 9.2 Acute & Chronic Inflammation, Granulomas, Systemic Effects & Tissue Repair 9.3 Hemodynamic Disorders: Edema, Hemorrhage, Thrombosis, Embolism, Infarction, DIC & Shock
10 Chapter 10: Pathology II: Genetics, Neoplasia, Immunity, Environment & Infection
10.1 Genetic Disorders & Neoplasia: Mendelian, Chromosomal, Non-Classic Inheritance, Tumor Biology & Markers 10.2 Immunopathology: Hypersensitivity, Autoimmunity, Immunodeficiency & Transplant Rejection 10.3 Environmental & Nutritional Pathology: Air Pollution, Tobacco, Metals, Occupational Lung Disease & Deficiency States 10.4 Pathology of Infectious Diseases: Transmission, Tissue Reaction Patterns & Diagnostic Morphology
11 Chapter 11: Pathology III: Gastrointestinal, Cardiovascular & Respiratory Pathology
11.1 Gastrointestinal, Hepatic, Biliary & Pancreatic Pathology 11.2 Cardiovascular & Collagen Pathology: Heart Failure, Congenital, Ischemic, Hypertensive, Valvular, Pericardial & Myocardial Disease 11.3 Respiratory Pathology: Atelectasis, Edema, ARDS, Obstructive & Restrictive Disease, Vascular Disease, Infections, Tumors & Pleura
12 Chapter 12: Pathology IV: Hematopoietic, Genitourinary, Endocrine & Nervous System Pathology
12.1 Hematopoietic Pathology: Anemias, Polycythemia, Bleeding Disorders, DIC & Lymphoid and Myeloid Neoplasms 12.2 Genitourinary Pathology: Glomerular, Tubulointerstitial, Vascular & Cystic Kidney Disease, Renal Tumors, Obstruction & Genital Disorders 12.3 Endocrine Pathology: Pancreas, Adrenal, Parathyroid, Thyroid & Pituitary Disorders 12.4 Nervous System Pathology: Cerebrovascular Disease, Edema & Herniation, Infections, Degenerative & Demyelinating Disease, Tumors
13 Chapter 13: Biochemistry I: Carbohydrate, Protein, Genetic & Energy Biochemistry
13.1 Carbohydrate Chemistry, Digestion, Glycolysis, Pyruvate Dehydrogenase & the Pentose Phosphate Pathway 13.2 Gluconeogenesis, Glycogen, Lipogenesis, Ketogenesis & Hormonal Control of Fuel Metabolism 13.3 Protein Digestion, Amino Acid Catabolism, the Urea Cycle, Heme Synthesis, Porphyrias & Bilirubin Metabolism 13.4 Amino Acids & Proteins: Structure, Properties, Separation, Specialized Products, Collagen & Protein Misfolding in Alzheimer Disease 13.5 Molecular Genetics & Enzymes: Replication, Repair, Gene Expression, Molecular Techniques, Lysosomal Storage Diseases & Enzyme Kinetics 13.6 Bioenergetics, the Citric Acid Cycle, Oxidative Phosphorylation, Muscle Energetics & Nucleotide Metabolism
14 Chapter 14: Biochemistry II: Respiratory, Nutritional, Immunologic & Cardiovascular Biochemistry
14.1 Respiratory Biochemistry: Hemoglobin, Oxygen Binding, Hemoglobinopathies, Thalassemias, Methemoglobin, Buffers & Acid-Base Balance 14.2 Nutrition Biochemistry: Dietary Standards (RENI to PDRI 2015), Food Guides, Protein Quality, Energy Expenditure, Breast Milk, Vitamins, Minerals & Blood Components 14.3 Immunology: Innate & Adaptive Immunity, the Immune Response, Antibodies, Complement, Cytokines & MHC 14.4 Cardiovascular Biochemistry: Cholesterol, Lipoproteins, Dyslipidemias, Atherogenesis, Myocardial Energetics, Biomarkers & Heart Failure
15 Chapter 15: Anatomy I: Thorax, Abdomen, Pelvis & Back
15.1 Thorax: Thoracic Wall, Breast, Pleura & Lungs, Mediastinum, Heart & Great Vessels 15.2 Abdomen: Abdominal Wall & Inguinal Region, Peritoneum, Viscera, Diaphragm & Posterior Abdominal Wall 15.3 Pelvis & Perineum: Bony Pelvis, Pelvic Floor, Pelvic Viscera, Vessels & Nerves, Perineal Pouches & the Anal Canal 15.4 Back & Spinal Column: Vertebrae, Curvatures, Joints, Back Muscles, Spinal Cord, Meninges & Cord Syndromes
16 Chapter 16: Anatomy II: Upper Limb, Lower Limb & Skin
16.1 Upper Limb: Bones, Superficial Veins, Shoulder Muscles, Axilla & Brachial Plexus, Arm, Cubital Fossa, Forearm, Hand & Joints 16.2 Lower Limb: Bones, Venous & Lymphatic Drainage, Thigh, Gluteal Region, Popliteal Fossa, Leg Compartments, Foot, Joints & Gait 16.3 Skin & Appendages: Epidermis, Junctions, Dermis, Subcutaneous Tissue, Fascia, Nerves, Vessels, Lymphatics, Hair, Nails & Glands
17 Chapter 17: Anatomy III: Head, Neck & Histology
17.1 Head I: Skull & Cranial Foramina, Scalp, Face & Parotid, Orbit, Temporal & Infratemporal Fossae, TMJ, Oral Region, Nose & Ear 17.2 Head II: Meninges & Dural Venous Sinuses, Brain Regions & Ventricles, Blood Supply, Cranial Nerves, Pituitary & Pineal, Brainstem Syndromes 17.3 Neck: Cervical Vertebrae & Hyoid, Fascial Layers, Superficial Muscles, Triangles, Root of the Neck, Visceral Layers & Lymphatics 17.4 Histology: Cells, Epithelium & Glands, Connective Tissue & Fat, Cartilage & Bone, Blood & Hematopoiesis, Muscle, Nerve, Vessels, Lymphoid Organs & Organ Histology
18 Chapter 18: Microbiology I: Foundations, Respiratory & Cardiovascular Infections
18.1 Microbiology Foundations: The Organ-System TOS, Specimens & Stains, Gram-Positive and Gram-Negative Bacteria 18.2 Respiratory Infections: Tonsillitis, Sinusitis & Mastoiditis, Bronchitis, Community-Acquired & Severe Pneumonia, Bronchiectasis and Paragonimiasis 18.3 Tuberculosis, Leprosy & Nontuberculous Mycobacteria: Pathogenesis, Diagnosis, NTP Regimens & Prevention 18.4 Cardiovascular Infections: Infective Endocarditis, Rheumatic Fever & Rheumatic Heart Disease, Myocarditis, Pericarditis and Septic Thrombophlebitis
19 Chapter 19: Microbiology II: Gastrointestinal & Nervous System Infections
19.1 Gastrointestinal Infections I: Gastroenteritis & Enterocolitis, Cholera, Typhoid & Salmonellosis, Shigellosis, Food Poisoning and Viral Hepatitis 19.2 Gastrointestinal Infections II: Amebiasis, Giardiasis & Cryptosporidiosis, Soil-Transmitted Helminths, Pinworm, Capillariasis and Tapeworms 19.3 Nervous System Infections: Meningitis & CSF Patterns, Encephalitis, Rabies and DOH PEP, Spinal Cord Infections, Tetanus & Botulism, Paralytic Shellfish Poisoning
20 Chapter 20: Microbiology III: Genitourinary, Reproductive, Blood & Skin Infections
20.1 Genitourinary Infections: Cystitis & Pyelonephritis, Urine Diagnostics, Urethritis, Balanoposthitis, Pelvic Inflammatory Disease and Genital Ulcers 20.2 Reproductive Tract Infections & STIs: Syphilis, Genital & Neonatal Herpes, HPV, Molluscum, CMV, Trichomoniasis & Vaginitis, Cervicitis, Prostatitis and Orchitis 20.3 Hematopoietic & Lymphatic Infections: Dengue and Other Hemorrhagic Fevers, Malaria, Lymphatic Filariasis, Lymphogranuloma Venereum and Epstein-Barr Virus 20.4 Integumentary Infections: Viral Exanthems (Measles, Mumps, Rubella, Varicella, Smallpox & Mpox, Fifth Disease), Herpesviruses, Fungal Skin Infections and Tick-Borne Diseases
21 Chapter 21: Microbiology IV: Musculoskeletal & Multisystemic Infections
21.1 Musculoskeletal & Soft-Tissue Infections: Osteomyelitis, Septic & Reactive Arthritis, Pyomyositis & Gas Gangrene, Cellulitis, Necrotizing Fasciitis and Bite Wounds 21.2 Multisystemic Infections I: Septicemia, Septicopyemia & Septic Shock, Leptospirosis and Schistosomiasis japonica 21.3 Multisystemic Infections II: HIV/AIDS Virology, the Philippine Epidemic & RA 11166, Diagnosis (rHIVda), ART, Prevention and Opportunistic Infections including Toxoplasmosis
22 Chapter 22: Obstetrics I: Prenatal Care, Labor & Obstetric Bleeding
22.1 Prenatal Care: Diagnosis of Pregnancy, Maternal Physiology, Dating, Nutrition & Supplements, Screening Tests and the DOH Antenatal Package 22.2 Labor & Parturition: Signs of Labor, Pelvis and Passenger, Stages and Cardinal Movements, Partograph, Fetal Monitoring, Dystocia, Shoulder Dystocia, Operative Delivery, Preterm Labor, PROM and Adolescent Pregnancy 22.3 Early Pregnancy Risks & Bleeding: Hyperemesis, Spontaneous Abortion, Recurrent Loss & Cervical Insufficiency, Ectopic Pregnancy, Hydatidiform Mole & Gestational Trophoblastic Neoplasia 22.4 Hemorrhagic Complications of Pregnancy: Placenta Previa, Abruption, Vasa Previa, Placenta Accreta Spectrum, Uterine Rupture, Third-Stage Management and Postpartum Hemorrhage
23 Chapter 23: Obstetrics II: Fetal, Hypertensive, Medical, Infectious & Postpartum Problems
23.1 Fetal Complications: Malpresentation & Breech, Macrosomia, Fetal Growth Restriction, Amniotic Fluid Disorders, Antepartum Surveillance, Rh Alloimmunization, Multiple Gestation and Post-Term Pregnancy 23.2 Hypertension & Diabetes in Pregnancy: Classification, Preeclampsia Pathogenesis and Prevention, Severe Features, Eclampsia & HELLP, Magnesium Sulfate, Gestational and Pregestational Diabetes 23.3 Medical & Surgical Disorders in Pregnancy: Drug Pharmacokinetics, Epilepsy, Thyroid, Heart Disease, SLE & APS, Asthma, Liver Disorders, Anemia, Dermatoses, Appendicitis, Gallstones, Stones and Trauma 23.4 Perinatal Infections: Triple Elimination (HIV, Syphilis, Hepatitis B), Group B Streptococcus, Chorioamnionitis, Gonorrhea & Chlamydia, Condyloma, Herpes and the TORCH Infections 23.5 Postpartum Care & Complications: Normal Puerperium, Postnatal Visits, Breastfeeding, Puerperal Fever and Infection, Mastitis, Late Hemorrhage, Mood Disorders, VTE and Postpartum Contraception
24 Chapter 24: Gynecology I: Benign Disorders, Infections & Contraception
24.1 Benign Lower Genital Tract Disorders & Pelvic Floor: Vulvar Dermatoses, Bartholin Cysts, Vaginal and Cervical Lesions, Premalignant Lesions, Pelvic Organ Prolapse, Urinary Incontinence and Fistula 24.2 Benign Upper Genital Tract Disorders: Leiomyoma, Adenomyosis & Endometriosis, Endometrial Polyps and Hyperplasia, Functional Cysts and Benign Ovarian Tumors, Adnexal Torsion and Tubal Disease 24.3 Infections of the Female Reproductive Tract: Burden & Screening, Syndromic Management, Vaginitis and Cervicitis, Pelvic Inflammatory Disease & Tubo-Ovarian Abscess, Genital Tuberculosis and Toxic Shock 24.4 Contraception & Family Planning: The RH Law, Effectiveness, Natural and Barrier Methods, Hormonal Methods, IUDs, Permanent Methods, Emergency Contraception and the WHO Eligibility Criteria
25 Chapter 25: Gynecology II: Reproductive Endocrinology, Oncology & Special Issues
25.1 Reproductive Endocrinology & Menstrual Disorders: The Menstrual Cycle, Puberty, Abnormal Uterine Bleeding (PALM-COEIN), Amenorrhea, PCOS, Hyperprolactinemia, Dysmenorrhea, Infertility, Menopause, HRT and Osteoporosis 25.2 Gynecologic Oncology: Cervical Cancer Screening, Staging & Treatment, Endometrial Cancer and Lynch Syndrome, Ovarian Tumors and BRCA, Vulvar and Vaginal Cancer, Survival and Quality of Life 25.3 Contemporary Issues & Pediatric and Adolescent Gynecology: Violence Against Women, Sexual Assault Care, Breast Disorders, Ethics of Maternal-Fetal Conflict, and Gynecologic Problems of Children and Adolescents
26 Chapter 26: Pediatrics I: Newborn, Growth, Nutrition, Immunization & Infections
26.1 The Newborn: Normal Findings and Variants, EINC (Unang Yakap), APGAR, Neonatal Resuscitation, Routine Care & Newborn Screening, Jaundice, Respiratory Distress, Hypoglycemia and Neonatal Sepsis 26.2 Growth, Development & Nutrition: Growth Parameters, Milestones and Red Flags, Speech Delay, Autism, ADHD & Global Delay, Breastfeeding and Feeding, Micronutrient Deficiencies, Malnutrition and Obesity 26.3 Immunization: RA 10152 and the National Immunization Program Schedule, Fully Immunized Child, School-Based Immunization, Other Recommended Vaccines, Vaccine Types, Cold Chain, Contraindications and AEFI 26.4 Pediatric Infectious Diseases: Bacterial (Diphtheria to Congenital Syphilis), Childhood TB, Viral Exanthems and Infections, Dengue in Children, Pediatric HIV, Protozoal, Helminthic and Fungal Infections
27 Chapter 27: Pediatrics II: Respiratory, Cardiovascular, Neurologic & Gastrointestinal Disorders
27.1 Pediatric Respiratory Disorders: IMCI Danger Signs and Cough Assessment, URI, Tonsillitis & Peritonsillar Abscess, Croup, Epiglottitis, Foreign Body, Bronchiolitis, Pneumonia, Pleural Effusion and Complications 27.2 Pediatric Cardiovascular & Collagen Disorders: Heart Sounds and Murmurs, Acyanotic and Cyanotic Congenital Heart Disease, Eisenmenger, Hypercyanotic Spells, Heart Failure, Rheumatic Fever, Hypertension, Endocarditis, Kawasaki, SLE, JIA, Dermatomyositis and Pediatric Resuscitation 27.3 Pediatric CNS Disorders: Febrile Seizures, Epilepsy Syndromes, Status Epilepticus, Meningitis and Encephalitis in Children, Cerebral Palsy, Hydrocephalus & Neural Tube Defects, Headache and Migraine, and Brain Tumors 27.4 Pediatric GI Disorders & Poisoning: Vomiting (Pyloric Stenosis, Atresias, Malrotation, Intussusception, GERD), Diarrhea and IMCI Rehydration Plans, Abdominal Pain, Constipation & Hirschsprung, Jaundice, Biliary Atresia & Choledochal Cyst, Hepatitis, Food Allergy, and Kerosene, Aspirin and INH Poisoning
28 Chapter 28: Pediatrics III: Genitourinary, Endocrine, Hematologic & Oncologic Disorders
28.1 Pediatric Genitourinary Disorders & Child Abuse: UTI and Vesicoureteral Reflux, Post-Streptococcal GN and Other Nephritides, Nephrotic Syndrome, AKI and HUS, CKD, Congenital Urogenital Anomalies, and Recognizing and Reporting Child Abuse 28.2 Pediatric Endocrine & Metabolic Disorders: Short Stature and Growth Hormone, Gigantism, Diabetes Insipidus, Congenital Hypothyroidism, Graves Disease & Goiter, Type 1 Diabetes and DKA, Congenital Adrenal Hyperplasia, Cushing Syndrome, Pheochromocytoma and Adrenal Crisis 28.3 Pediatric Hematology, Allergy & Immunology: Normal Hemogram and Immunoglobulins by Age, Anemias (Iron Deficiency, Thalassemia, G6PD, Spherocytosis, Aplastic), Bleeding Disorders (ITP, Hemophilia, vWD, DIC, Vitamin K), IgA Vasculitis, Rashes and Drug Reactions, Asthma, Allergic Rhinitis and Primary Immunodeficiencies 28.4 Pediatric Oncology & Genetics: Leukemias and Lymphomas, Retinoblastoma, Wilms Tumor, Neuroblastoma, Ewing Sarcoma and Osteosarcoma; Sex Chromosome and Autosomal Disorders, Inborn Errors of Metabolism and the Dysmorphic ("Odd-Looking") Child
29 Chapter 29: Preventive Medicine I: The Physician as Health Care Provider
29.1 The Physician as Health Care Provider I: Natural History of Disease, Disease Causation, Levels of Prevention and Primary Care Across the Clinical Rotations 29.2 The Physician as Health Care Provider II: The Filipino Family and Family Assessment Tools, Health Education and Promotion, Behavior Change Models and Geriatric Medicine 29.3 The Physician as Health Care Provider III: The Primary Health Care Concept (Alma-Ata, Astana, Philippine PHC) and Mental Health in Primary Care under RA 11036
30 Chapter 30: Preventive Medicine II: Philippine Health Care System & Community Medicine
30.1 The Philippine Health Care System: DOH Structure, Levels of Care and Referral, Devolution under RA 7160, the Universal Health Care Act (RA 11223), PhilHealth and YAKAP, and Leading Causes of Morbidity and Mortality 30.2 Epidemiology, Surveillance & Outbreaks: Measures of Disease Occurrence and Association, Rates, Endemic and Epidemic Levels, PIDSR and RA 11332 Notifiable Diseases, the Ten Steps of Outbreak Investigation and Epidemic Curves 30.3 DOH Programs & Environmental Sanitation: TB, Dengue, Rabies, Leprosy, Helminth and Other Disease Programs; the Sanitation Code (PD 856), Water Supply and Potability, Excreta and Solid Waste, Food Sanitation and Health Care Waste 30.4 Community Medicine: Principles of Public Health Administration and Program Planning, Vital Health Indices (Infant and Maternal Mortality), the Ecologic Concept of Health, Lifestyle and Non-Communicable Diseases, Health-Seeking Behavior and Traditional Medicine
31 Chapter 31: Preventive Medicine III: Manager, Researcher & Social Mobilizer
31.1 The Physician as Administrative Manager: Communication and Interpersonal Skills, Teamwork, Adult Learning, Occupational Health (RA 11058), Bioethics, Palliative Care, School Health, Organ Transplantation and Birth and Death Certificates 31.2 The Physician as Researcher I: The Research Process and Proposal, Research Ethics, Study Designs and Meta-Analysis, Demography and Vital Statistics, Evidence-Based Medicine and Quality Assurance 31.3 The Physician as Researcher II: Biostatistics (Data Types, Distributions, Central Tendency and Dispersion, Confidence Intervals, Hypothesis Testing and Test Selection) and Screening Tests (Validity, Predictive Values, Likelihood Ratios, Biases and Program Criteria) 31.4 The Physician as Social Mobilizer and Leader: Philippine Health Laws, Decrees and Executive Orders, Principles of Social Mobilization and Community Organizing, and Disaster Risk Reduction and Management in Health
32 Chapter 32: Pharmacology I: Principles, Cardiovascular & Nervous System Therapeutics
32.1 Pharmacology Foundations: The Pharmacology TOS, Pharmacokinetics, Drug Metabolism and Interactions, Pharmacodynamics, Adverse Drug Reactions and Monitoring, Autonomic Pharmacology, and Philippine Prescribing Rules 32.2 Cardiovascular Pharmacology I: Cardiac Arrest and ACLS Drugs, Bradycardia and Complete Heart Block, Antiarrhythmics, Anticoagulation in Atrial Fibrillation, Antianginals, ACS Therapy and Fibrinolysis, Pericarditis and Endocarditis Regimens 32.3 Cardiovascular Pharmacology II: Antihypertensives and Diuretics, Hypertensive Emergencies, Vasopressors and Inotropes in Shock, Heart Failure GDMT and Digoxin, and Lipid-Lowering Therapy 32.4 Nervous System Pharmacology I: Antiseizure Drugs and Status Epilepticus, Headache and Migraine, Vertigo, Stroke Thrombolysis and Secondary Prevention, Encephalopathy, Dementia, ADHD, Parkinson Disease and Movement Disorders, Raised Intracranial Pressure and CNS Infections
33 Chapter 33: Pharmacology II: Psychiatric, Respiratory & Genitourinary Therapeutics
33.1 Nervous System Pharmacology II: Antidepressants and Their Toxicity, Serotonin Syndrome, Anxiolytics and Hypnotics, Antipsychotics, EPS and NMS, Lithium and Mood Stabilizers, Sleep Disorders, Agitation and Alcohol Withdrawal 33.2 Respiratory Pharmacology: Cough and Colds, Allergic Rhinitis, Asthma (Controllers, Relievers, Exacerbations), COPD, Anti-TB Drugs, Antibiotics for Pneumonia and Bronchitis, and Lung Cancer Therapy 33.3 Genitourinary Pharmacology I: Antimicrobial Classes and Toxicities, and Drug Treatment of UTI, Pyelonephritis, Gonorrhea, Chlamydia, Syphilis, Genital Herpes, Genital Warts, PID, Vaginitis, Prostatitis and Orchitis 33.4 Genitourinary Pharmacology II: Kidney Stones, Nephrotic and Nephritic Disease, Drug Dosing in Kidney Disease and Hyperkalemia, Benign Prostatic Hyperplasia, Erectile Dysfunction, Renal Cell Carcinoma and Prostate Cancer Therapy
34 Chapter 34: Pharmacology III: Digestive, Endocrine, Skin & Musculoskeletal Therapeutics
34.1 Digestive Pharmacology: Portal Hypertension and Variceal Bleeding, Acid-Peptic Disease, H. pylori and GERD, Antiemetics, Laxatives and Antidiarrheals, Biliary and Pancreatic Disease, GI Infections and Parasites, Viral Hepatitis, C. difficile, Candidiasis and GI Cancer Chemotherapy 34.2 Endocrine Pharmacology I: Diabetes Mellitus Drugs (Metformin, Sulfonylureas, SGLT2 Inhibitors, GLP-1 Agonists, DPP-4 Inhibitors, Thiazolidinediones, Insulins), Choosing Therapy by Comorbidity, DKA and HHS, and Hypoglycemia 34.3 Endocrine Pharmacology II: Pituitary Disorders (GH Deficiency, Acromegaly, Prolactinoma, Diabetes Insipidus, Panhypopituitarism), Thyroid Drugs and Thyroid Storm, Calcium and Parathyroid Disorders, Adrenal Disorders and Corticosteroids 34.4 Cutaneous and Musculoskeletal Pharmacology: Cellulitis and Abscess, Drug-Induced Skin Reactions (SJS/TEN), Pain Management (Paracetamol, NSAIDs, Opioids), Osteoporosis, Rheumatoid Arthritis and Osteoarthritis, Septic and TB Arthritis, Gout, SLE and Psoriasis
35 Chapter 35: Surgery I: Basic Surgical Principles
35.1 Basic Surgical Principles I: The Surgery TOS, Fluids and Electrolytes, Acid-Base Balance, the Metabolic Response to Injury, Surgical Nutrition and Blood Transfusion 35.2 Basic Surgical Principles II: Shock and Surgical Critical Care, Hemorrhagic Shock and Massive Transfusion, ATLS Primary and Secondary Survey, Chest and Abdominal Trauma, Head and Spine Injury, Pelvic Fractures and Burns 35.3 Basic Surgical Principles III: Preoperative Assessment, Wound Healing, Surgical Infection and Asepsis, Postoperative Fever, Surgical Oncology, Immunology and Transplantation, Anesthesia and Patient Safety
36 Chapter 36: Surgery II: Abdomen, Breast & Hernia
36.1 Abdomen I: Esophagus (Hiatal Hernia, GERD, Achalasia, Caustic Injury, Barrett, Boerhaave, Mallory-Weiss, Cancer), Stomach and Duodenum (Peptic Ulcer Complications, Upper GI Bleeding, Gastric Cancer, GIST), Small Bowel (Obstruction, Ileus, Tumors, Typhoid and TB), Retroperitoneum and Abdominal Wall 36.2 Abdomen II: Gallstones, Cholecystitis, Choledocholithiasis and Cholangitis, Obstructive Jaundice, Liver (Cirrhosis, Portal Hypertension, Abscesses, Tumors and Hepatocellular Carcinoma), Pancreas (Acute and Chronic Pancreatitis, Pancreatic Cancer) and Spleen (Splenectomy, OPSI) 36.3 Abdomen III: Acute Appendicitis, Colonic Obstruction and Volvulus, Lower GI Bleeding, Diverticular Disease, Colorectal Polyps and Cancer, Hemorrhoids, Anal Fissure, Perianal Abscess and Fistula 36.4 Breast, Hernia and Skin and Soft Tissue: Benign Breast Masses, Breast Cancer Evaluation and Treatment, Groin and Abdominal Wall Hernias, Benign Skin and Soft-Tissue Tumors, Skin Cancers and Soft-Tissue Sarcoma
37 Chapter 37: Surgery III: Surgical Specialties
37.1 Head and Neck, Thyroid, Parathyroid, Endocrine and Bariatric Surgery and Otorhinolaryngology: Neck Masses and Head and Neck Cancer, Salivary Glands, Thyroid Nodules and Cancer, Goiter and Hyperthyroidism Surgery, Hyperparathyroidism, Adrenal Surgery, Bariatric Surgery, Nasal Polyps, Epistaxis, Vertigo, Hearing Loss and ENT Infections 37.2 Specialty I: Neurosurgery (Raised Intracranial Pressure and Herniation, Head Injury and Hematomas, Spontaneous Intracranial Hemorrhage, CNS and Peripheral Nerve Tumors, Spinal Cord Compression, Neurosurgical Infections) and Ophthalmology (Glaucoma, Cataract, Ophthalmic Emergencies) 37.3 Specialty II: Thoracic and Cardiovascular Surgery (Pleural Effusion and Empyema, Lung Cancer, Mediastinal Masses, Surgical Heart Disease, Aortic Aneurysm and Dissection, Peripheral Arterial and Venous Disease), Urology (Stones, Infections, Torsion, BPH, Urologic Tumors) and Gynecologic Surgery 37.4 Specialty III: Plastic and Reconstructive Surgery (Skin Grafts and Flaps, Cleft Lip and Palate, Facial Fractures, Hand Injuries), Orthopedics (Fractures, Dislocations, Bone and Joint Infections, Bone Tumors) and Pediatric Surgery (Hernias, CDH, Esophageal Atresia, Obstruction, Hirschsprung Disease, Neonatal Jaundice, Tumors)
38 Chapter 38: Medicine I: Cardiovascular, Digestive & Endocrine Medicine
38.1 Cardiovascular Medicine I: Hypertension and Secondary Causes, Dyslipidemia, Stable Angina and Acute Coronary Syndromes, Post-MI Complications, Heart Failure and Shock Syndromes 38.2 Cardiovascular Medicine II: Tachyarrhythmias and Bradyarrhythmias, Atrial Fibrillation, Sudden Cardiac Death and Brugada Syndrome, Cardiac Arrest, Valvular and Rheumatic Heart Disease, Infective Endocarditis, Myocarditis and Pericardial Disease 38.3 Gastroenterology and Hepatology: GERD and Peptic Ulcer Disease, Upper and Lower GI Bleeding, Diarrhea and GI Infections, Acute Pancreatitis and Biliary Disease, Viral Hepatitis, Cirrhosis and Portal Hypertension, Liver and GI Cancers 38.4 Endocrinology: Diabetes Mellitus Diagnosis, Treatment and Complications, DKA and HHS, Thyroid Disease, Pituitary Disorders, Adrenal Disorders (Cushing, Aldosteronism, Addison, Pheochromocytoma), Calcium and Parathyroid Disorders, Obesity and Metabolic Syndrome
39 Chapter 39: Medicine II: Hematology, Systemic Infections, Renal & Respiratory Medicine
39.1 Hematology, Immunology and Systemic Infections: Anemias (Iron Deficiency, Thalassemia, G6PD Deficiency, Megaloblastic, Hemolytic), Acute and Chronic Leukemias and Their Emergencies, Allergic Disorders, Dengue in Adults, COVID-19, Malaria and HIV/AIDS Opportunistic Infections 39.2 Nephrology: Acute Kidney Injury, Chronic Kidney Disease and Dialysis, Sodium and Potassium Disorders, Acid-Base Analysis, Urinary Tract Infections, Glomerular Diseases (Nephritic and Nephrotic), Kidney Stones, Renal Tumors and Sexually Transmitted Infections 39.3 Pulmonology and Critical Care: Acute Respiratory Failure and Oxygen Therapy, Bronchial Asthma, COPD, Community- and Hospital-Acquired Pneumonia, Pulmonary Tuberculosis and TB Infection, Pulmonary Embolism, Lung Cancer and ARDS
40 Chapter 40: Medicine III: Rheumatology, Dermatology, Neurology, Rehabilitation & Psychiatry
40.1 Rheumatology and Dermatology: Approach to Arthritis, Osteoarthritis, Rheumatoid Arthritis, Gout, Spondyloarthritis, SLE and Other Connective Tissue Diseases, Vasculitis and Myalgias, Bone Tumors, Common Skin Lesions, Skin Infections and Infestations, Eczema, Psoriasis, Severe Drug Eruptions and Skin Signs of Systemic Disease 40.2 Neurology and Rehabilitation Medicine: Stroke and TIA (Localization, Thrombolysis, Thrombectomy, Secondary Prevention), Intracranial Hemorrhage, Seizures and Status Epilepticus, Meningitis and Encephalitis, Tetanus and Rabies, Parkinsonism, Neuromuscular and Degenerative Diseases, Dementia, CNS Tumors, Post-Stroke Rehabilitation and Musculoskeletal Disorders 40.3 Psychiatry: Mental Status Examination, Depressive Disorders, Bipolar Disorder, Schizophrenia and Other Psychoses, Anxiety Disorders, OCD and Trauma-Related Disorders, Substance Use, and Acute Psychiatric Emergencies (Suicide Risk, Agitation, Withdrawal, Wernicke Encephalopathy)
39.2 Nephrology: Acute Kidney Injury, Chronic Kidney Disease and Dialysis, Sodium and Potassium Disorders, Acid-Base Analysis, Urinary Tract Infections, Glomerular Diseases (Nephritic and Nephrotic), Kidney Stones, Renal Tumors and Sexually Transmitted Infections
Key Takeaways Explain This Topic AI
AKI is a creatinine rise of 0.3 mg/dL or more within 48 hours, 1.5 times baseline within 7 days, or urine output below 0.5 mL/kg/hour for 6 hours (KDIGO).
Hyperkalemia with ECG changes is treated first with IV calcium gluconate to stabilize the heart, then insulin with glucose and salbutamol to shift potassium, then removal.
Correct chronic hyponatremia by no more than 8 to 10 mmol/L in 24 hours; severe symptoms are treated with a 150 mL bolus of 3% saline.
Nephritic syndrome causes hematuria with RBC casts, hypertension and edema (e.g., post-streptococcal GN); nephrotic syndrome causes proteinuria over 3.5 g a day, hypoalbuminemia, edema and hyperlipidemia.
Uncomplicated gonorrhea is treated with ceftriaxone 500 mg IM once (and doxycycline if chlamydia is not excluded); early syphilis with a single dose of benzathine penicillin G 2.4 million units IM.
Last updated: October 2026
Why this area matters
Chronic kidney disease is a major and growing cause of illness and death in the Philippines , and kidney failure (mostly from diabetes and hypertension , and chronic glomerulonephritis ) is one of the most common reasons for hemodialysis , which PhilHealth helps to fund. AKI from leptospirosis , dengue, sepsis and dehydration is frequent. Sexually transmitted infections are rising among young adults. The PLE asks you to classify AKI, read electrolytes and ABGs, and choose first-line therapy.
Acute Kidney Injury (AKI) & Dialysis Indications
Acute kidney injury is an abrupt decline in renal filtration capacity occurring over hours to days, diagnosed and staged by the Kidney Disease: Improving Global Outcomes (KDIGO) criteria:
Stage 1: Serum creatinine increase ≥ 0.3 mg/dL \ge 0.3\text{ mg/dL} ≥ 0.3 mg/dL ( ≥ 26.5 μ mol/L \ge 26.5\text{ }\mu\text{mol/L} ≥ 26.5 μ mol/L ) within 48 hours, or 1.5 to 1.9 1.5\text{ to }1.9 1.5 to 1.9 times baseline within 7 days; or urine output < 0.5 mL/kg/hour < 0.5\text{ mL/kg/hour} < 0.5 mL/kg/hour for 6 to 12 hours.
Stage 2: Serum creatinine 2.0 to 2.9 2.0\text{ to }2.9 2.0 to 2.9 times baseline; or urine output < 0.5 mL/kg/hour < 0.5\text{ mL/kg/hour} < 0.5 mL/kg/hour for ≥ 12 hours \ge 12\text{ hours} ≥ 12 hours .
Stage 3: Serum creatinine ≥ 3.0 \ge 3.0 ≥ 3.0 times baseline, or increase ≥ 4.0 mg/dL \ge 4.0\text{ mg/dL} ≥ 4.0 mg/dL ( ≥ 353.6 μ mol/L \ge 353.6\text{ }\mu\text{mol/L} ≥ 353.6 μ mol/L ), or initiation of renal replacement therapy; or urine output < 0.3 mL/kg/hour < 0.3\text{ mL/kg/hour} < 0.3 mL/kg/hour for ≥ 24 hours \ge 24\text{ hours} ≥ 24 hours , or anuria for ≥ 12 hours \ge 12\text{ hours} ≥ 12 hours .
Etiologic Differentiation of AKI
Diagnostic Parameter Prerenal Azotemia Intrinsic AKI (Acute Tubular Necrosis) Postrenal Azotemia
Primary Mechanism Renal hypoperfusion without parenchymal tissue damage (dehydration, CHF, sepsis, NSAIDs, ACEi/ARBs) Direct tubular epithelial cellular damage (ischemic shock or nephrotoxins: aminoglycosides, IV contrast, myoglobin) Mechanical obstruction of urinary collecting system (BPH, bilateral calculi, pelvic malignancy)
BUN / Serum Creatinine Ratio > 20 : 1 > 20:1 > 20 : 1 (increased urea reabsorption) 10 − 15 : 1 10-15:1 10 − 15 : 1 (parallel loss of urea and creatinine clearance) Variable; initially > 20 : 1 > 20:1 > 20 : 1 , transitions to < 15 : 1 < 15:1 < 15 : 1 with parenchymal injury
Fractional Excretion of Sodium ( F E N a FENa FEN a ) < 1 % < 1\% < 1% (avidity to conserve sodium) > 2 % > 2\% > 2% (tubular inability to reabsorb sodium) Variable (usually > 1 % > 1\% > 1% in established obstruction)
Fractional Excretion of Urea ( F E U r e a FEUrea FE U re a ) < 35 % < 35\% < 35% (diagnostic when diuretics invalidate F E N a FENa FEN a ) > 50 % > 50\% > 50% Variable
Urine Sodium ( U N a U_{Na} U N a ) < 20 mEq/L < 20\text{ mEq/L} < 20 mEq/L > 40 mEq/L > 40\text{ mEq/L} > 40 mEq/L Variable ( > 40 mEq/L > 40\text{ mEq/L} > 40 mEq/L )
Urine Osmolality > 500 mOsm/kg > 500\text{ mOsm/kg} > 500 mOsm/kg (intact concentrating ability) < 350 mOsm/kg < 350\text{ mOsm/kg} < 350 mOsm/kg (isosthenuric; loss of concentrating capacity) < 350 mOsm/kg < 350\text{ mOsm/kg} < 350 mOsm/kg
Urine Sediment Microscopy Normal, or transparent hyaline casts "Muddy brown" granular casts , renal tubular epithelial cells Variable; crystals, hematuria, or bland
Definitive Initial Management Restore renal perfusion with isotonic crystalloids; withdraw offending agents Discontinue nephrotoxins; maintain euvolemia; avoid fluid overload Immediate decompression: Foley catheter, ureteral stent, or percutaneous nephrostomy
Emergent Indications for Dialysis: The "AEIOU" Mnemonic
A — Acidosis: Severe metabolic acidosis refractory to medical therapy ( pH < 7.1 − 7.2 \text{pH} < 7.1-7.2 pH < 7.1 − 7.2 ).
E — Electrolytes: Severe, refractory hyperkalemia ( K + > 6.5 mEq/L \text{K}^+ > 6.5\text{ mEq/L} K + > 6.5 mEq/L ) with ECG abnormalities (peaked T waves, PR prolongation, widened QRS, sine wave) refractory to medical shifting (calcium gluconate, insulin/dextrose, albuterol, loop diuretics).
I — Ingestions / Intoxications: Dialyzable toxic substances (mnemonic SLIME : Salicylates, Lithium, Isopropanol, Methanol, Ethylene glycol).
O — Overload: Refractory pulmonary edema and volume overload unresponsive to maximal diuretic escalation.
U — Uremia: Symptomatic uremic manifestations: uremic encephalopathy (altered mental status, asterixis, seizures), uremic pericarditis (pericardial friction rub, risk of tamponade), or uremic bleeding diathesis (platelet dysfunction due to circulating guanidinosuccinic acid).
Chronic Kidney Disease (CKD) & Complications
CKD is defined as abnormalities of kidney structure or function persisting for ≥ 3 months \ge 3\text{ months} ≥ 3 months , with implications for health.
KDIGO Staging by eGFR & Albuminuria
eGFR Categories (mL/min/1.73 m²):
G1: Normal or high ( ≥ 90 \ge 90 ≥ 90 with structural kidney damage).
G2: Mildly decreased ( 60 − 89 60 - 89 60 − 89 ).
G3a: Mildly to moderately decreased ( 45 − 59 45 - 59 45 − 59 ).
G3b: Moderately to severely decreased ( 30 − 44 30 - 44 30 − 44 ).
G4: Severely decreased ( 15 − 29 15 - 29 15 − 29 ).
G5: Kidney failure ( < 15 < 15 < 15 or on chronic dialysis).
Albuminuria Categories (Urine Albumin-to-Creatinine Ratio, UACR):
A1 (Normal to mildly increased): < 30 mg/g < 30\text{ mg/g} < 30 mg/g ( < 3 mg/mmol < 3\text{ mg/mmol} < 3 mg/mmol ).
A2 (Moderately increased): 30 − 300 mg/g 30 - 300\text{ mg/g} 30 − 300 mg/g (formerly microalbuminuria).
A3 (Severely increased): > 300 mg/g > 300\text{ mg/g} > 300 mg/g (includes nephrotic-range proteinuria > 2 , 200 mg/g > 2,200\text{ mg/g} > 2 , 200 mg/g ).
Major Complications of Progressive CKD
Anemia of CKD: Normochromic, normocytic anemia primarily caused by decreased peritubular interstitial synthesis of erythropoietin (EPO) . Evaluated when hemoglobin is < 12.0 g/dL < 12.0\text{ g/dL} < 12.0 g/dL in women or < 13.0 g/dL < 13.0\text{ g/dL} < 13.0 g/dL in men. Prior to initiating Erythropoiesis-Stimulating Agents (ESAs: epoetin alfa, darbepoetin), iron stores must be replete (transferrin saturation ≥ 20 % \ge 20\% ≥ 20% and serum ferritin ≥ 100 − 200 ng/mL \ge 100-200\text{ ng/mL} ≥ 100 − 200 ng/mL ). Target hemoglobin with ESAs is 10.0 to 11.5 g/dL 10.0\text{ to }11.5\text{ g/dL} 10.0 to 11.5 g/dL ; targeting higher levels ( > 13.0 g/dL > 13.0\text{ g/dL} > 13.0 g/dL ) increases strokes, vascular access thrombosis, and cardiovascular mortality.
CKD-Mineral and Bone Disorder (CKD-MBD): Declining GFR impairs phosphate excretion (hyperphosphatemia) and diminishes renal 1-alpha-hydroxylase activity, reducing active 1 , 25 -(OH) 2 D 3 1,25\text{-(OH)}_2\text{D}_3 1 , 25 -(OH) 2 D 3 (calcitriol) synthesis. The resulting hypocalcemia and hyperphosphatemia stimulate parathyroid hyperplasia, triggering severe secondary hyperparathyroidism and high-turnover bone disease ( osteitis fibrosa cystica / renal osteodystrophy). Treatment entails dietary phosphate restriction, non-calcium phosphate binders ( Sevelamer , Lanthanum), active vitamin D analogues (Calcitriol, Paricalcitol), and calcimimetics ( Cinacalcet ).
More on kidney failure:
AKI causes common in the Philippines: leptospirosis (after floods; jaundice with AKI and often non-oliguric hypokalemic renal failure), dengue, sepsis, rhabdomyolysis, contrast, herbal remedies and NSAIDs.
Acute interstitial nephritis: drugs (penicillins, NSAIDs, PPIs), with fever, rash, eosinophilia and white cell casts . Stop the drug, with steroids for some.
Slowing CKD progression:
- BP control (KDIGO suggests systolic below 120 mmHg if tolerated);
- an ACE inhibitor or ARB at maximum tolerated dose for albuminuria;
- an SGLT2 inhibitor for most patients with eGFR of 20 or more;
- finerenone in diabetic kidney disease with albuminuria;
- glucose control, statins, stopping smoking;
avoiding nephrotoxins and adjusting drug doses.
Renal replacement: prepare for dialysis or transplantation when eGFR falls below about 20 to 30 (an arteriovenous fistula takes months to mature). Kidney transplantation gives the best survival and quality of life.
Sodium and potassium disorders
Hyponatremia (sodium below 135 mmol/L):
check serum osmolality : high (hyperglycemia, mannitol), normal (pseudohyponatremia from lipids or protein) or low (true hypotonic hyponatremia) ;
assess volume status :
- hypovolemic : GI losses (urine sodium below 20), thiazides and adrenal insufficiency (urine sodium above 20);
- euvolemic : SIADH , hypothyroidism, secondary adrenal insufficiency, primary polydipsia, beer potomania;
- hypervolemic : heart failure, cirrhosis and nephrotic syndrome;
severe symptoms (seizures, coma): 3% saline 150 mL over 20 minutes , repeated if needed, aiming for a rise of 4 to 6 mmol/L;
chronic hyponatremia : correct by no more than 8 to 10 mmol/L in 24 hours (8 in high-risk patients such as those with alcohol use or malnutrition) to prevent osmotic demyelination (dysarthria, quadriparesis).
Hypernatremia: water loss with poor access to water (elderly, infants, diabetes insipidus). Replace the free water deficit slowly (no more than about 10 to 12 mmol/L a day in chronic cases) to avoid cerebral edema.
Hyperkalemia:
causes: CKD and AKI, ACE inhibitors, ARBs, spironolactone , NSAIDs, trimethoprim, adrenal insufficiency, acidosis, tissue breakdown (rhabdomyolysis, tumor lysis) and pseudohyperkalemia (hemolyzed sample);
ECG progression : peaked T waves , PR prolongation and flattened P waves, widened QRS , then a sine wave and VF or asystole;
treatment :
stabilize the heart : IV calcium gluconate if there are ECG changes;
shift potassium into cells : regular insulin 10 units with glucose , nebulized salbutamol , and bicarbonate if acidotic;
remove potassium : loop diuretics, potassium binders (sodium zirconium cyclosilicate, patiromer, sodium polystyrene sulfonate) and dialysis .
Hypokalemia:
causes: diarrhea , vomiting, diuretics , hyperaldosteronism, insulin and beta-agonists, hypomagnesemia (correct magnesium first), periodic paralysis (thyrotoxic in Asian men) and renal tubular acidosis;
- ECG : flat T waves, U waves and arrhythmias;
- weakness, ileus and rhabdomyolysis;
replace orally if possible; IV potassium no faster than about 10 to 20 mmol/hour through a peripheral line.
Acid-base analysis
Steps:
Look at the pH (acidemia below 7.35, alkalemia above 7.45).
Find the primary disorder (bicarbonate for metabolic, PaCO2 for respiratory).
Check compensation : in metabolic acidosis, expected PaCO2 is 1.5 × HCO3 + 8 (± 2) (Winter formula).
Calculate the anion gap : Na minus (Cl plus HCO3), normal about 8 to 12, corrected for low albumin.
In high anion gap acidosis, compare the change in anion gap with the change in bicarbonate to detect a hidden second disorder.
High anion gap metabolic acidosis: lactic acidosis , ketoacidosis (diabetic, alcoholic, starvation), renal failure and toxins ( methanol , ethylene glycol , salicylates , iron, isoniazid). An osmolal gap suggests toxic alcohols.
Normal anion gap (hyperchloremic) acidosis: diarrhea , renal tubular acidosis, ureteral diversion and saline infusion.
Metabolic alkalosis:
saline-responsive (urine chloride below 20): vomiting , nasogastric suction, diuretics;
saline-resistant : hyperaldosteronism, Cushing syndrome, Bartter and Gitelman syndromes.
Respiratory acidosis: hypoventilation (COPD, sedatives, neuromuscular weakness). Respiratory alkalosis: anxiety, pain, PE, early salicylate toxicity, sepsis and pregnancy.
Urinary tract infections
Acute uncomplicated cystitis in non-pregnant women: dysuria, frequency and urgency without fever. Treated with nitrofurantoin for 5 days , fosfomycin once, or TMP-SMX where resistance is low. A urine culture is not routinely needed.
Acute pyelonephritis:
- fever, flank pain, costovertebral angle tenderness , often with vomiting;
- urine culture first;
- an oral fluoroquinolone for mild cases if resistance is low, or IV ceftriaxone for admitted patients;
imaging for failure to improve in 48 to 72 hours, to look for obstruction or abscess .
Complicated UTI: men, pregnancy, catheters, obstruction, diabetes and immunosuppression. Treated longer and guided by culture.
Asymptomatic bacteriuria: treat only in pregnancy and before urologic procedures that breach the mucosa. Do not treat elderly or catheterized patients without symptoms.
Recurrent UTI: behavioral measures, vaginal estrogen after menopause, and prophylaxis.
Glomerular diseases
Feature Nephritic syndrome Nephrotic syndrome
Urine Hematuria with RBC casts , dysmorphic RBCs, proteinuria below 3.5 g a day Proteinuria above 3.5 g a day , fatty casts (oval fat bodies)
Other features Hypertension , edema, oliguria, AKI Hypoalbuminemia , edema , hyperlipidemia , hypercoagulability
Examples Post-streptococcal GN , IgA nephropathy , lupus nephritis, ANCA vasculitis, anti-GBM disease Minimal change (children), membranous (adults; anti-PLA2R ), FSGS , diabetic nephropathy , amyloidosis
Post-streptococcal GN: 1 to 3 weeks after pharyngitis or 3 to 6 weeks after skin infection (impetigo) , with cola-colored urine, edema, hypertension, low C3 and a high ASO or anti-DNase B. Usually resolves with supportive care (salt and fluid restriction, diuretics, antihypertensives).
IgA nephropathy: gross hematuria within 1 to 2 days of a respiratory infection ("synpharyngitic"), normal complement. It is the most common primary GN worldwide.
Rapidly progressive GN (crescents): anti-GBM disease (Goodpasture: lung hemorrhage), ANCA vasculitis and immune complex GN. Needs urgent biopsy, steroids, cyclophosphamide or rituximab , and plasma exchange for anti-GBM.
Complications of nephrotic syndrome: venous thrombosis (renal vein thrombosis, especially in membranous nephropathy), infections, hyperlipidemia and AKI.
Secondary causes to look for in the Philippines: hepatitis B (membranous), hepatitis C, HIV, SLE, diabetes, malaria and drugs.
Kidney biopsy in adults with nephrotic syndrome or unexplained nephritis.
Kidney stones and renal tumors
Acute renal colic: NSAIDs for pain, non-contrast CT, alpha-blockers for distal ureteral stones of 5 to 10 mm, and urgent drainage for infection with obstruction (see urology).
Prevention:
- fluid intake to make more than 2 to 2.5 L of urine a day ;
- a normal calcium diet (restricting calcium raises oxalate absorption);
- low sodium and less animal protein;
thiazides for hypercalciuria, potassium citrate for hypocitraturia and uric acid stones, and allopurinol for hyperuricosuria.
Renal tumors:
renal cell carcinoma (clear cell, linked to smoking, obesity, VHL): hematuria, flank pain and mass, often found by chance on imaging; paraneoplastic polycythemia, hypercalcemia and hypertension;
- angiomyolipoma (tuberous sclerosis);
- Wilms tumor in children;
- urothelial cancer of the renal pelvis;
treated by nephrectomy (see surgery).
Sexually transmitted infections
Urethral discharge in men: gonorrhea and chlamydia . Treat gonorrhea with ceftriaxone 500 mg IM once , adding doxycycline 100 mg twice daily for 7 days if chlamydia is not excluded.
Vaginal discharge:
- bacterial vaginosis : fishy odor, clue cells, pH above 4.5, treated with metronidazole ;
- trichomoniasis : frothy discharge, strawberry cervix, treated with metronidazole for the patient and partner;
candidiasis : thick white discharge with itching, normal pH, treated with azoles.
Genital ulcers:
- primary syphilis : a painless indurated chancre with painless nodes;
- herpes simplex : painful multiple vesicles and ulcers , treated with acyclovir or valacyclovir;
- chancroid ( Haemophilus ducreyi ): a painful ulcer with suppurative nodes;
LGV : transient ulcer then painful matted nodes.
Syphilis:
- diagnosed with a non-treponemal test (RPR, VDRL) and a treponemal test (TPHA, TPPA);
- primary, secondary and early latent syphilis : benzathine penicillin G 2.4 million units IM once ;
- late latent syphilis: 3 weekly doses;
- neurosyphilis : IV aqueous penicillin;
- the Jarisch-Herxheimer reaction (fever after the first dose) is self-limited;
screen every pregnant woman to prevent congenital syphilis.
Syndromic management treats the likely causes of a syndrome at the first visit where laboratory tests are unavailable. Partner notification , condoms, HIV testing , HPV and hepatitis B vaccination, and HIV PrEP for high-risk people are part of care.